Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Disease area: Airway diseases

Abstract

[Background] Chronic Obstructive Pulmonary Disease (COPD) is characterized by dyspnea. It‘s the factor for exercise limitations, activity daily living limitations and quality of life deterioration. We examined the effect of short-acting beta-2-agonist (SABA) inhalation just before pulmonary rehabilitations.
[Material and methods] Stable COPD patients were randomized to two groups with or without inhalation of SABA just before each home exercise. We measured 6-min walk distance (6MWD), muscle strength and St. George‘s Respiratory Questionnaire (SGRQ) before and after 3-month exercise program.
[Results] After 3-month exercise program, both groups showed improvements of muscle strength, exercise tolerance (6MWD), health related quality of life (SGRQ). The SABA inhalation group had greater improvement than the no inhalation group. Adverse effects did not occurred in SABA inhalation group.
[Conclusions] The SABA inhalation just before home exercise will be effective in pulmonary rehabilitation.

Rating:

Share or cite this content

Citations should be made in the following way:
M. Hasegawa, K. Dobashi, T. Horie, K. Shirakura (Mabashi, Japan). The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease. Eur Respir J 2009; 34: Suppl. 53, 527

Member's Comments

No comment yet.

Related content which might interest you: Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 The effect of nutrition on the pulmonary functions in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Tiotropium in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 205-206 Year: 2002 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease> Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure Year: 2003 The effect of early pulmonary rehabilitation on the treatment of ICU chronic obstructive pulmonary disease with severe respiratory failure Source: International Congress 2018 – Muscles and diaphragm, and quality improvement Year: 2018